Advanced search
Publication Cover
Journal of Pain & Palliative Care Pharmacotherapy Volume 25, 2011 - Issue 2
Submit an article Journal homepage
705
Views
18
CrossRef citations to date
0
Altmetric
ARTICLES

Methylnaltrexone for Opioid-Induced Constipation in Patients With Advanced Illness: A 3-Month Open-Label Treatment Extension Study

Arthur G. Lipman Arthur G. Lipman, PharmD, FASHP, is Professor of Pharmacotherapy, Adjunct Professor of Anesthesiology, and Director of Clinical Pharmacology at the Pain Management Center, University of Utah, Salt Lake City, Utah, USA.Correspondence[email protected]
,
Sloan Karver Sloan B. Karver, MD, FAAHPM, is Program Leader, Psychosocial and Palliative Care, Moffitt Cancer Center and Assistant Professor of Oncologic Sciences, University of South Florida, Tampa, Florida, USA; at the time of this study she was with Gulfside Regional Hospice, New Port Richey, Florida, USA.
,
Gail Austin Cooney Gail Austin Cooney, MD, FAAHPM, is Assistant Medical Director, Hospice of Palm Beach County, Inc., West Palm Beach, Florida, USA.
,
Nancy Stambler Nancy Stambler, MS, is Senior Director, Biometics.
&
Robert J. Israel Robert J. Israel, MD, is Senior Vice President for Medical Affairs, Progenics Pharmaceuticals, Inc., Tarrytown ,New York, USA.
Pages 136-145 | Accepted 16 Mar 2011, Published online: 09 Jun 2011

REFERENCES

  • Pappagallo M. Incidence, prevalence, and management of opioid bowel dysfunction. Am J Surg. 2001;182(5A Suppl):11S–18S.
  • Walsh T. Prevention of opioid side effects. J Pain Symptom Manage. 1990;5:362–367.
  • Walsh T. Oral morphine in chronic cancer pain. Pain. 1984;18:1–11.
  • Cameron. Constipation related to narcotic therapy. A protocol for nurses and patients. Cancer Nurs. 1992;15:372–377.
  • Sykes NP. The relationship between opioid use and laxative use in terminally ill cancer patients. Palliat Med.1998;12: 375–382.
  • McNicol E, Horowicz-Mehler N, Fisk RA, Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review. J Pain. 2003;4:231–256.
  • Schug SA, Zech D, Grond S. Adverse effects of systemic opioid analgesics. Drug Saf. 1992;7:200–213.
  • Bates JJ, Foss JF, Murphy DB. Are peripheral opioid antagonists the solution to opioid side effects? Anesth Analg. 2004;98:116–122.
  • Kurz A, Sessler DI. Opioid-induced bowel dysfunction: pathophysiology and potential new therapies. Drugs. 2003;63:649–671.
  • Liu M, Wittbrodt E. Low-Dose oral naloxone reverses opioid-induced constipation and analgesia. J Pain Symptom Manage. 2002;23:48–53.
  • Paulson DM, Kennedy DT, Donovick RA, Alvimopan: an oral, peripherally acting, [mu]-opioid receptor antagonist for the treatment of opioid-induced bowel dysfunction—a 21-day treatment-randomized clinical trial. J Pain. 2005;6: 184–192.
  • Yuan C-S, Wei G, Foss JF, O'Connor M, Karrison T, Osinski J. Effects of subcutaneous methylnaltrexone on morphine-induced peripherally mediated side effects: a double-blind randomized placebo-controlled trial. J Pharmacol Exp Therap. 2002;300:118–123.
  • Meissner W, Schmidt U, Hartmann M, Kath R, Reinhart K. Oral naloxone reverses opioid-associated constipation. Pain. 2000;84:105–109.
  • Brown DR, Goldberg LI. The use of quaternary narcotic antagonists in opiate research. Neuropharmacology. 1985;24: 181–191.
  • Yuan C-S, Foss JF, O'Connor M, Effects of enteric-coated methylnaltrexone in preventing opioid-induced delay in oral-cecal transit time. Clin Pharmacol Ther. 2000;67:398– 404.
  • Manara L, Bianchi G, Ferretti P, Tavani A. Inhibition of gastrointestinal transit by morphine in rats results primarily from direct drug action on gut opioid sites. J Pharmacol Exp Therap. 1986;237:945–949.
  • Tavani. Morphine is most effective on gastrointestinal propulsion in rats by intraperitoneal route: evidence for local action. Life Sci. 1980;27:2211–2217.
  • Thomas J, Karver S, Cooney GA, Methylnaltrexone for opioid-induced constipation in advanced illness. N Engl J Med. 2008;358:2332–2343.
  • Himmelsbach C. The morphine abstinence syndrome, its nature and treatment. Ann Intern Med. 1941;15:829– 839.
  • Christakis NA, Lamont EB, Smith JL, Parkes CM. Extent and determinants of error in doctors’ prognoses in terminally ill patients: prospective cohort study. BMJ. 2000;320:469– 473.
  • De Schepper HU, Cremonini F, Park MI, Camilleri M. Opioids and the gut: pharmacology and current clinical experience. Neurogastroenterol Motil. 2004;16:383–394.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.